CD4+ and GITR+ T cells were preferentially accumulated at the post-ischemic cortex and mice treated with GITR-stimulating antibodies had increased post-stroke inflammatory responses with increased apoptosis of iNSPCs. Here, TNFRSF18 is linked to stroke disorder.